Endovascular treatment for superior vena cava obstruction
Journal Title: Postępy Nauk Medycznych - Year 2015, Vol 28, Issue 2
Abstract
Introduction. Superior vena cava syndrome (SVCS) is common complication of malignancy, the lung cancer is the most common cause. The clinical indication for superior vena cava (SVC) endovascular treatment is allevation of superior vena cava syndrome (SVCS) caused by malignant obstruction.Aim. Evaluation of safety and efficacy of SVC stenting in patients with malignant superior vena cava syndrome (SVCS) – our experience.Material and methods. Between 2011 and 2014, data of 112 patients with SVC syndrome, mostly of malignant aetiology, were retrospectively collected. The study included 68 men and 44 women (mean age – 64; range 43-79 years).Results. Stent placement was technically successful in 98% cases. Two stents were found to be obstructed after several months and patients needed repeated angioplasty. There was no stent migration to the right atrium. Haemoptysis was observed in one patient and pulmonary embolism in two cases. There were no major remote complications.Conclusions. Endovascular stenting has become a safe and cost effective treatment for patients with SVCS, providing rapid relief of symptoms and improving their quality of life. Endovascular stenting should be performed in each patient with SVCS.
Authors and Affiliations
Monika Miazga, Tomasz Jargiełło, Anna Drelich-Zbroja, Klaudia Karska, Krzysztof Pyra, Michał Sojka, Marcin Kowalik, Małgorzata Szczerbo-Trojanowska
Keywords
Related Articles
- EP ID EP54992
- DOI -
- Views 154
- Downloads 0
Skin-mucous side effects of the retinoids in the therapy of acne vulgaris
<b>Introduction. </b>Acne vulgaris is one of the most commonly diagnosed dermatosis in patients aged 11-30 years. It is believed to be found in about 80% of patients in this age group but if c...
Clinical profile of hypertrophic cardiomyopathy in children – own experience
<b>Introduction.</b> Hypertrophic cardiomyopathy is a genetically determined myocardial disease characterized by left ventricular hypertrophy, which is not secondary to congenital heart diseas...
A systemic therapy of metastatic renal cancer. A review
For many years metastatic renal cancer was considered as a chemotherapy-refractory disease. The only two modestly active agents were interleukin 2 and interferon alpha but very few patients benefited from immunotherapy....
Cardiac arrest out of hospital – etiology, prognosis, perspectives of treatment – preliminary report
91 patients post cardiac arrest in pre-hospital period were treated in Cardiac Intensive Care Unit in the years 2004-2009. The mortality rate in the whole group of patients was about 62 % There was a tendency to lower mo...
Hypertrophic cardiomyopathy in a newborn with a rare genetic syndrome – diagnostic and therapeutic difficulties
Hypertrophic cardiomyopathy is characterized by left ventricular hypertrophy with the absence of other cardiac anomaly as arterial hypertension or congenital heart disease. Clinical symptoms usually depend on the age of...